FC
GMAB icon

Financial Consulate’s Genmab GMAB Stock Holding History

Financial Consulate’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.87K Sell
250
-20
-7% -$532 ﹤0.01% 775
2026
Q1 		$7.25K Buy
270
+60
+29% +$1.8K ﹤0.01% 716
2025
Q4 		$6.47K Buy
210
+20
+11% +$623 ﹤0.01% 693
2025
Q3 		$5.83K Buy
+190
New +$4.63K ﹤0.01% 629

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Financial Consulate's GMAB Position: Q2 2026 in Review

Financial Consulate reduced its Genmab (GMAB) stake by 7.4% in Q2 2026, selling an estimated $532 and leaving 250 shares worth $6.87K. The position accounts for ﹤0.01% of the portfolio, ranked #775.

Financial Consulate first reported a position in GMAB in Q3 2025 and has held it in 4 quarters since. The position peaked at $7.25K in Q1 2026. 292 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Financial Consulate held 250 shares of Genmab worth $6.87K as of Q2 2026.
  • Financial Consulate sold 20 Genmab shares in Q2 2026, an estimated $532.
  • Genmab made up ﹤0.01% of Financial Consulate's portfolio in Q2 2026, its #775 holding.
  • Financial Consulate first reported a position in Genmab in Q3 2025 and has held it in 4 quarters since.
  • Financial Consulate's Genmab position peaked at $7.25K in Q1 2026.
  • 292 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Financial Consulate's 13F filing for Q2 2026, filed 23 Jul 2026.